ACatechol

ACatechol, founded in 2016 and headquartered in Pasadena, California, specializes in developing biological-protein-based adhesives. The company's core mission is to create innovative, bioinspired surface technologies that address critical health and safety issues. Their product line includes primers and glues designed for various applications, with a particular focus on preventing hospital-acquired infections through durable, germicidal surface coatings. ACatechol leverages biomimetic surface engineering to offer long-lasting solutions that enhance public health and safety.

Notable figures associated with ACatechol include its founding team of scientists and engineers who have secured funding through prestigious grants such as the NSF COVID-19 SBIR grant. This grant facilitated the development of their Gemini surface technology, which provides long-lasting germicidal efficacy to prevent the transmission of infectious diseases. ACatechol's innovations have had a significant impact on reducing hospital-acquired infections and improving dental bonding techniques, positioning the company as a leader in bioinspired adhesive technologies.